Supplementary Data 1 from A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer
Authors:
- Alessandro D. SantinASAlessandro D. Santin
- Dana M. RoqueDRDana M. Roque
- Eric R. SiegelESEric R. Siegel
- Victoria M. EttorreVEVictoria M. Ettorre
- Michelle GreenmanMGMichelle Greenman
- Blair McNamaraBMBlair McNamara
- Katyayani PapatlaKPKatyayani Papatla
- Aparna KailasamAKAparna Kailasam
- Natalia BuzaNBNatalia Buza
- Mitchell ClarkMCMitchell Clark
- Pei HuiPHPei Hui
- Peter DottinoPDPeter Dottino
Open Access
- 3 August 2026
- other
- Published by American Association for Cancer Research (AACR)